A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)

Clinical trial NCT06735755 · RECRUITING

Trial details

NCT number: NCT06735755
Sponsor: Beam Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glycogen Storage Disease Type Ia

Start date: 2024-12-06
Primary completion: 2027-12-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.